According to the literature, rare pancreatic G3 NETs that have progressed from G1/G2 NETs may harbor mutations in MEN1 and ATRX genes, as well as concurrent mutations in TP53 and RB1, hinting at a potential progression from NETs to NEC (16, 19). Here, ATRX is linked to neuroendocrine carcinoma.